EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

Paez, J. Guillermo, Jänne, Pasi A., Lee, Jeffrey C., Tracy, Sean, Greulich, Heidi, Gabriel, Stacey, Herman, Paula, Kaye, Frederic J. +9 more·2004·Science
DOI 10.1126/science.1099314

Cited by (1,066)

Items 901–1,000 of 1,066

  1. Targeting EGFR <sup>L858R/T790M</sup> and EGFR <sup>L858R/T790M/C797S</sup> resistance mutations in NSCLC: Current developments in medicinal chemistry
    Lu, Xiaoyun, Yu, Lei, Zhang, Zhang, Ren, Xiaomei, Smaill, Jeff B., Ding, Ke · 2018 · Medicinal Research Reviews
  2. A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives
    Russo, Alessandro, Franchina, Tindara, Rita Ricciardi, Giuseppina Rosaria, Picone, Antonio, Ferraro, Giuseppa, Zanghì, Mariangela, Toscano, Giuseppe, Giordano, Antonio, Adamo, Vincenzo · 2015 · Oncotarget
  3. Predictive Markers in Breast and Other Cancers: A Review
    Michael Joe Duffy · 2005 · Clinical Chemistry
  4. Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
    Soji Kakiuchi, Yataro Daigo, Nobuhisa Ishikawa, Chiyuki Furukawa, Tatsuhiko Tsunoda, Seiji Yano, Kazuhiko Nakagawa, Takashi Tsuruo, Nobuoki Kohno, Masahiro Fukuoka et al. · 2004 · Human Molecular Genetics
  5. Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours
    Marc‐Eric Halatsch, Ursula I. Schmidt, Julianne Behnke‐Mursch, Andreas Wilhelm Unterberg, Christian Rainer Wirtz · 2006 · Cancer Treatment Reviews
  6. Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
    Zhenyi Niu, Runsen Jin, Yan Zhang, Hecheng Li · 2022 · Signal Transduction and Targeted Therapy
  7. Multigene amplification and massively parallel sequencing for cancer mutation discovery
    Fredrik Dahl, Johan Stenberg, Simon Fredriksson, Katrina M. Welch, Michael Zhang, Mats F. Nilsson, David Bicknell, Walter Fred Bodmer, Ronald Wayne Davis, Hanlee P. Ji · 2007 · Proceedings of the National Academy of Sciences
  8. Proteins, drug targets and the mechanisms they control: the simple truth about complex networks
    Robyn P. Araujo, Lance A. Liotta, Emanuel F. Petricoin · 2007 · Nature Reviews Drug Discovery
  9. Oncogenic <i>BRAF</i> Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120
    Chen, Shih-Hsun, Zhang, Youyan, Van Horn, Robert D., Yin, Tinggui, Buchanan, Sean, Yadav, Vipin, Mochalkin, Igor, Wong, Swee Seong, Yue, Yong Gang, Huber, Lysiane et al. · 2016 · Cancer Discovery
  10. Effects of Erlotinib in <i>EGFR</i> Mutated Non-Small Cell Lung Cancers with Resistance to Gefitinib
    Costa, Daniel B., Nguyen, Kim-Son H., Cho, Byoung C., Sequist, Lecia V., Jackman, David M., Riely, Gregory J., Yeap, Beow Y., Halmos, Balázs, Kim, Joo H., Jänne, Pasi A. et al. · 2008 · Clinical Cancer Research
  11. Lung Cancer in Never Smokers: Molecular Profiles and Therapeutic Implications
    Charles M. Rudin, Érika Ávila-Tang, Curtis C. Harris, James Gordon Herman, Fred R. Hirsch, William J. Pao, Ann G. Schwartz, Kirsi Vähäkangas, Jonathan M. Samet · 2009 · Clinical Cancer Research
  12. Lung Cancers with Concomitant EGFR Mutations and ALK Rearrangements: Diverse Responses to EGFR-TKI and Crizotinib in Relation to Diverse Receptors Phosphorylation
    Jin‐Ji Yang, Xu‐Chao Zhang, Jian Su, Chong‐Rui Xu, Qing Hua Zhou, Hong-Xia Tian, Zhi Xie, Hua-Jun Chen, Yi-Sheng Huang, Ben‐Yuan Jiang et al. · 2014 · Clinical Cancer Research
  13. The Expression of Three Genes in Primary Non–Small Cell Lung Cancer Is Associated with Metastatic Spread to the Brain
    Helena Grinberg-Rashi, Efrat Ofek, Marina Perelman, Jozef Škarda, Pnina Yaron, Marián Hajdúch, Jasmin Jacob–Hirsch, Ninette Amariglio, Meir Krupsky, David A. Simansky et al. · 2009 · Clinical Cancer Research
  14. Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
    Jin‐Yuan Shih, Chien‐Hung Gow, Chong‐Jen Yu, Chih‐Hsin Yang, Yih‐Leong Chang, Meng‐Feng Tsai, Ya‐Chieh Hsu, Kuan‐Yu Chen, Wen‐Pin Su, Pan‐Chyr Yang · 2005 · International Journal of Cancer
  15. Early Prediction of Nonprogression in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib By Using [18F]Fluorodeoxyglucose and [18F]Fluorothymidine Positron Emission Tomography
    Thomas Zander, Matthias Scheffler, Lucia Nogová, Carsten Kobe, Walburga Engel-Riedel, Martin Hellmich, Irini Papachristou, Karin Toepelt, Andreas Draube, Lukas Carl Heukamp et al. · 2011 · Journal of Clinical Oncology
  16. HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer
    Michael F. Press, Richard S. Finn, David Cameron, Angelo Di Leo, Charles E. Geyer, Ivonne E. Villalobos, Angela Santiago, Roberta Guzman, Armen Gasparyan, Yanling Ma et al. · 2008 · Clinical Cancer Research
  17. The Use of Genomics in Clinical Trial Design
    Richard M Simon · 2008 · Clinical Cancer Research
  18. Mapping Molecular Networks Using Proteomics: A Vision for Patient-Tailored Combination Therapy
    Emanuel F. Petricoin, Verena E. Bichsel, Valerie S. Calvert, Virginia A. Espina, Mary E. Winters, Lynn Young, Claudio Belluco, Bruce J. Trock, Marc E. Lippman, David A. Fishman et al. · 2005 · Journal of Clinical Oncology
  19. A Functional Common Polymorphism in a Sp1 Recognition Site of the Epidermal Growth Factor Receptor Gene Promoter
    Wanqing Liu, Federico Innocenti, Michael H. Wu, Apurva A. Desai, M. Eileen Dolan, Edwin H. Cook, Mark J. Ratain · 2005 · Cancer Research
  20. Functional Copy-Number Alterations in Cancer
    Taylor, Barry S., Barretina, Jordi, Socci, Nicholas D., DeCarolis, Penelope, Ladanyi, Marc, Meyerson, Matthew, Singer, Samuel, Sander, Chris · 2008 · PLoS ONE
  21. Epidermal Growth Factor Receptor in Pancreatic Cancer
    Melissa Oliveira‐Cunha, William G. Newman, Ajith Kumar Siriwardena · 2011 · Cancers
  22. Fibroblast Growth Factor Receptor 1 Gene Amplification Is Associated With Poor Survival and Cigarette Smoking Dosage in Patients With Resected Squamous Cell Lung Cancer
    Hye Ryun Kim, Dae Joon Kim, Dae Ryong Kang, Jin Gu Lee, Sun Min Lim, Chang Young Lee, Sun Young Rha, Mi Kyung Bae, Young Joo Lee, Se Hoon Kim et al. · 2012 · Journal of Clinical Oncology
  23. Randomized Phase III Trial of Platinum-Doublet Chemotherapy Followed by Gefitinib Compared With Continued Platinum-Doublet Chemotherapy in Japanese Patients With Advanced Non–Small-Cell Lung Cancer: Results of a West Japan Thoracic Oncology Group Trial (WJTOG0203)
    Koji Takeda, Toyoaki Hida, Tosiya Shun Sato, Masahiko Ando, Takashi Seto, Miyako Satouchi, Yukito Ichinose, Nobuyuki Katakami, Nobuyuki Yamamoto, Shinzoh Kudoh et al. · 2009 · Journal of Clinical Oncology
  24. Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis
    Jacob A. Miller, Elizabeth Bennett, Roy Xiao, Rupesh R Kotecha, Samuel T. Chao, Michael A. Vogelbaum, Gene H. Barnett, Lilyana Angelov, Erin Sennett Murphy, Jennifer S. Yu et al. · 2016 · International Journal of Radiation Oncology*Biology*Physics
  25. Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement
    Shuangshuang Li, Min Jiang, Lu Wang, Shuwen Yu · 2020 · Biomedicine & Pharmacotherapy
  26. PTPN11 is a central node in intrinsic and acquired resistance to targeted cancer drugs
    Prahallad, Anirudh, Heynen, Guus J.J.E., Germano, Giovanni, Willems, Stefan M., Evers, Bastiaan, Vecchione, Loredana, Gambino, Valentina, Lieftink, Cor, Beijersbergen, Roderick L., Di Nicolantonio, Federica et al. · 2015 · Cell Reports
  27. Radiogenomic Analysis to Identify Imaging Phenotypes Associated with Drug Response Gene Expression Programs in Hepatocellular Carcinoma
    Kuo, Michael D., Gollub, Jeremy, Sirlin, Claude B., Ooi, Clara, Chen, Xin · 2007 · Journal of Vascular and Interventional Radiology
  28. Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy
    Kancha, Rama Krishna, von Bubnoff, Nikolas, Peschel, Christian, Duyster, Justus · 2009 · Clinical Cancer Research
  29. Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma
    Rachel G. Liao, Joonil Jung, Jeremy H. Tchaicha, Matthew D. Wilkerson, Andrey Sivachenko, Ellen M. Beauchamp, Qingsong Liu, Trevor J. Pugh, Chandra Sekhar Pedamallu, David Neil Hayes et al. · 2013 · Cancer Research
  30. Somatic Mutations of Epidermal Growth Factor Receptor in Bile Duct and Gallbladder Carcinoma
    Francesco Leone, Giuliana Cavalloni, Ymera Pignochino, Ivana Sarotto, Renato Ferraris, Wanda Piacibello, Tiziana Venesio, Lorenzo Capussotti, Mauro Risio, Massimo Aglietta · 2006 · Clinical Cancer Research
  31. Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles
    Eejung Kim, Nina Ilić, Yashaswi Shrestha, Lihua Zou, Atanas Kamburov, Cong Zhu, Xiaoping Yang, Rakela Lubonja, Nancy H. Tran, Cindy Nguyen et al. · 2016 · Cancer Discovery
  32. Identifying EGFR mutations in lung adenocarcinoma by noninvasive imaging using radiomics features and random forest modeling
    Tian-Ying Jia, Jun-Feng Xiong, Xiaoyang Li, Wen Juan Yu, Zhiyong Xu, Xu‐Wei Cai, Jingchen Ma, Yacheng Ren, Rasmus Larsson, Jie Zhang et al. · 2019 · European Radiology
  33. Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer
    Bradley A. Schiff, Andrea Barber McMurphy, Samar A. Jasser, Maher N. Younes, Dao Doan, Orhan Gazi Yigitbasi, Seungwon Kim, Ge Zhou, Mahitosh Mandal, Benjamin Nebiyou Bekele et al. · 2004 · Clinical Cancer Research
  34. Predictors of the Response to Gefitinib in Refractory Non–Small Cell Lung Cancer
    Kyu‐Sik Kim, Ju-Yeon Jeong, Young‐Chul Kim, Kook-Joo Na, Yun‐Hyeon Kim, Sung‐Ja Ahn, Sun-Mi Baek, Chang-Soo Park, Chang-Min Park, Yu‐Il Kim et al. · 2005 · Clinical Cancer Research
  35. Gefitinib for non-small-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp
    Sutani, A, Nagai, Y, Udagawa, K, Uchida, Y, Koyama, N, Murayama, Y, Tanaka, T, Miyazawa, H, Nagata, M, Kanazawa, M et al. · 2006 · British Journal of Cancer
  36. Hedgehog Fights Back: Mechanisms of Acquired Resistance against Smoothened Antagonists
    Ciara Metcalfe, Frédéric J. de Sauvage · 2011 · Cancer Research
  37. Kinase Domain Mutations in Cancer: Implications for Small Molecule Drug Design Strategies
    Jack Andrew Bikker, Natasja Brooijmans, Allan Wissner, Tarek S. Mansour · 2009 · Journal of Medicinal Chemistry
  38. Non-small cell lung carcinoma (NSCLC): Implications on molecular pathology and advances in early diagnostics and therapeutics
    Hafiza Padinharayil, Jinsu Varghese, Mithun Chacko John, Golgodu Krishnamurthy Rajanikant, Cornelia M. Wilson, Minnatallah Al-Yozbaki, Kaviyarasi Renu, Saikat Dewanjee, Rupa Sanyal, Abhijit Dey et al. · 2022 · Genes & Diseases
  39. Association of <i>KRAS</i> and <i>EGFR</i> mutations with survival in patients with advanced lung adenocarcinomas
    Johnson, Melissa L., Sima, Camelia S., Chaft, Jamie, Paik, Paul K., Pao, William, Kris, Mark G., Ladanyi, Marc, Riely, Gregory J. · 2013 · Cancer
  40. Japanese Lung Cancer Research Trends and Performance in Science Citation Index
    Yuh‐Shan Ho, Hiroaki Satoh, Shih-Yuan Lin · 2010 · Internal Medicine
  41. Recent Advances on the Molecular Mechanisms Involved in the Drug Resistance of Cancer Cells and Novel Targeting Therapies
    Murielle Mimeault, Ralph J. Hauke, SK Batra · 2007 · Clinical Pharmacology & Therapeutics
  42. Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
    Jorge Sergio Reis-Filho, Fernanda Milanezi, Sílvia Carvalho, Peter T. Simpson, Dawn Steele, Kay Savage, Maryou B. K. Lambros, Emílio Marcelo Pereira, Jahn M. Nesland, Sunil R. Lakhani et al. · 2005 · Breast Cancer Research
  43. <i>In vitro</i> modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant <i>EGFR</i> mutants in non-small-cell lung cancer
    Hirano, Toshiyuki, Yasuda, Hiroyuki, Tani, Tetsuo, Hamamoto, Junko, Oashi, Ayano, Ishioka, Kota, Arai, Daisuke, Nukaga, Shigenari, Miyawaki, Masayoshi, Kawada, Ichiro et al. · 2015 · Oncotarget
  44. Targeted therapies for non-small cell lung cancer
    Wolfram C. M. Dempke, Tamás Sütö, Martin Reck · 2009 · Lung Cancer
  45. Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer
    Kimihide Yoshida, Yasushi Yatabe, Ji Young Park, Junichi Shimizu, Yoshitsugu Horio, Keitaro Matsuo, Takayuki Kosaka, Tetsuya Mitsudomi, Toyoaki Hida · 2007 · Journal of Thoracic Oncology
  46. Expression patterns of potential therapeutic targets in prostate cancer
    Tobias Zellweger, Christoph Ninck, Michael Bloch, Martina Mirlacher, Pasi A. Koivisto, Heikki J. Helin, Michael Jörg Mihatsch, Thomas C. Gasser, Lukas Bubendorf · 2004 · International Journal of Cancer
  47. CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma
    Pierre Saintigny, Erminia Massarelli, Steven Hsesheng Lin, Young‐Ho Ahn, Yulong Chen, Sangeeta Goswami, Baruch Erez, Michael S. O’Reilly, Diane Liu, J. Jack Lee et al. · 2012 · Cancer Research
  48. Targeting Aurora B kinase prevents and overcomes resistance to EGFR inhibitors in lung cancer by enhancing BIM- and PUMA-mediated apoptosis
    Kosuke Tanaka, Helena Alexandra Yu, Shaoyuan Yang, Song Han, S. Duygu Selçuklu, Kwanghee Kim, Shriram Ramani, Yogesh Tengarai Ganesan, Allison F. Moyer, Sonali Sinha et al. · 2021 · Cancer Cell
  49. Mutations of the epidermal growth factor receptor in non-small cell lung cancer – Search and destroy
    S.K. Chan, William John Gullick, Mark E. Hill · 2005 · European Journal of Cancer
  50. EGFR, HER2 and VEGF Pathways
    Michael F. Press, Heinz‐Josef Lenz · 2007 · Drugs
  51. Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium
    Pacheco-Pinedo, Eugenia C., Durham, Amy C., Stewart, Kathleen M., Goss, Ashley M., Lu, Min Min, DeMayo, Francesco J., Morrisey, Edward E. · 2011 · Journal of Clinical Investigation
  52. Capecitabine Plus Erlotinib in Gemcitabine-Refractory Advanced Pancreatic Cancer
    Matthew H. Kulke, Lawrence Scott Blaszkowsky, David P. Ryan, Jeffrey William Clark, Jeffrey A. Meyerhardt, Andrew Xiuxuan Zhu, Peter C. Enzinger, Eunice Lee Kwak, Alona Muzikansky, Colleen E. Lawrence et al. · 2007 · Journal of Clinical Oncology
  53. Somatic alterations in the human cancer genome
    Barbara A. Weir, Xiaojun Zhao, Matthew M. Meyerson · 2004 · Cancer Cell
  54. Personalized Medicine: Marking a New Epoch in Cancer Patient Management
    Maria Diamandis, Nicole M. A. White, George Makram Yousef · 2010 · Molecular Cancer Research
  55. Ultrasensitive Measurement of Hotspot Mutations in Tumor DNA in Blood Using Error-Suppressed Multiplexed Deep Sequencing
    Azeet Narayan, Nicholas John Carriero, Scott N. Gettinger, Jeannie Kluytenaar, Kevin Robert Kozak, Torunn Ingrid Yock, Nicole E. Muscato, Pedro Ugarelli, Roy H. Decker, Abhijit A. Patel · 2012 · Cancer Research
  56. Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor 2 (HER2), and Epidermal Growth Factor Receptor Expression and Benefit From Lapatinib in a Randomized Trial of Paclitaxel With Lapatinib or Placebo As First-Line Treatment in HER2-Negative or Unknown Metastatic Breast Cancer
    Richard S. Finn, Michael F. Press, Judy Dering, Michael C. Arbushites, Maria T. Koehler, Cristina Oliva, Lisa Simone Williams, Angelo Di Leo · 2009 · Journal of Clinical Oncology
  57. Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell Carcinoma
    Hiromitsu Hatakeyama, Haixia Cheng, Pamela S. Wirth, Ashley Counsell, Samuel Marcrom, Carey Burton Wood, Paula Raffin Pohlmann, Jill Gilbert, Barbara A. Murphy, Wendell Gray Yarbrough et al. · 2010 · PLoS ONE
  58. Therapies Directed Against Epidermal Growth Factor Receptor in Aerodigestive Carcinomas
    Michalis V. Karamouzis, Jennifer Rubin Grandis, Athanassios E. Argiris · 2007 · JAMA
  59. Prioritizing targets for precision cancer medicine
    Fabrice André, Elaine R. Mardis, Maximilian P Salm, Jean‐Charles Soria, Lillian L. Siu, Charles Swanton · 2014 · Annals of Oncology
  60. Advances in Chemotherapy of Non-small Cell Lung Cancer
    Julian R. Molina, Alex A. Adjei, James R. Jett · 2006 · CHEST Journal
  61. Mechanisms of Acquired Resistance to Targeted Cancer Therapies
    Mark R. Lackner, Timothy Richard Wilson, Jeff Settleman · 2012 · Future Oncology
  62. Current practices and guidelines for clinical next-generation sequencing oncology testing
    Samuel P. Strom, Samuel P. Strom · 2016 · Cancer Biology and Medicine
  63. Mutational and Epigenetic Evidence for Independent Pathways for Lung Adenocarcinomas Arising in Smokers and Never Smokers
    Shinichi Toyooka, Masaki Tokumo, Hisayuki Shigematsu, Keitaro Matsuo, Hiroaki Asano, Kunitoshi Tomii, Shuji Ichihara, Makoto Suzuki, Motoi Aoe, Hiroshi Date et al. · 2006 · Cancer Research
  64. Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma
    Makoto Sonobe, T Manabe, Hiromi Wada, Fumihiro Tanaka · 2005 · British Journal of Cancer
  65. ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors
    Cheng-Po Huang, Meng‐Feng Tsai, Tzu‐Hua Chang, Wei-Chien Tang, Suyu Chen, Hsiao-Hsuan Lai, Ting‐Yu Lin, James Chih‐Hsin Yang, Pan‐Chyr Yang, Jin‐Yuan Shih et al. · 2012 · Cancer Letters
  66. Development of transcriptomic biomarker signature in human saliva to detect lung cancer
    Lei Zhang, Hua Xiao, Hui Zhou, Silverio Santiago, Jay M. Lee, Edward B. Garon, Jieping Yang, Ole Brinkmann, Xinmin Yan, David Akin et al. · 2012 · Cellular and Molecular Life Sciences
  67. Variation in tissue-specific gene expression among natural populations
    Andrew Whitehead, Douglas L. Crawford · 2005 · Genome biology
  68. Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
    Tzu‐Hua Chang, Meng-Feng Tsai, Kang‐Yi Su, Shang-Gin Wu, Cheng-Po Huang, Sung‐Liang Yu, Yung‐Luen Yu, Chou‐Chin Lan, Chih-Hsin Yang, Shwu-Bin Lin et al. · 2010 · American Journal of Respiratory and Critical Care Medicine
  69. Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease
    Crispin T. Hiley, John P. C. Le Quesne, George Santis, Rowena Sharpe, David González de Castro, Gary Middleton, Charles Swanton · 2016 · The Lancet
  70. The Farnesyl Transferase Inhibitor (FTI) SCH66336 (lonafarnib) Inhibits Rheb Farnesylation and mTOR Signaling
    Andrea D. Basso, Asra Mirza, Gongjie Liu, Brian J. Long, Walter Robert Bishop, Paul T. Kirschmeier · 2005 · Journal of Biological Chemistry
  71. Restoration of Wnt-7a Expression Reverses Non-small Cell Lung Cancer Cellular Transformation through Frizzled-9-mediated Growth Inhibition and Promotion of Cell Differentiation
    Robert A. Winn, Lindsay A. Marek, Sun‐Young Han, Karen J. Rodriguez, Nicole Rodriguez, Mandy Hammond, Michelle M. Van Scoyk, Henri Acosta, Justin E. Mirus, Nicholas P. Barry et al. · 2005 · Journal of Biological Chemistry
  72. Combined Use of ALK Immunohistochemistry and FISH for Optimal Detection of ALK-Rearranged Lung Adenocarcinomas
    Lynette Marie Sholl, Stanislawa Weremowicz, Stacy W. Gray, Kwok‐Kin Wong, Lucian R. Chirieac, Neal Ian Lindeman, Jason L. Hornick · 2013 · Journal of Thoracic Oncology
  73. Validating cancer drug targets
    John D. Benson, Ying-Nan P. Chen, Susan Cornell-Kennon, Marion Dorsch, Sunkyu Kim, Magdalena Leszczyniecka, William R. Sellers, Christoph Lengauer C · 2006 · Nature
  74. Associations Between Mutations and Histologic Patterns of Mucin in Lung Adenocarcinoma
    Kyuichi Kadota, Yi‐Chen Yeh, Sandra P. D’Angelo, Andre Luis Moreira, Deborah Kuk, Camelia S. Sima, Gregory J. Riely, Maria E. Arcila, Mark G. Kris, Valerie W. Rusch et al. · 2014 · The American Journal of Surgical Pathology
  75. Efficacy of Erlotinib for Brain and Leptomeningeal Metastases in Patients with Lung Adenocarcinoma Who Showed Initial Good Response to Gefitinib
    Tatsuya Katayama, Junichi Shimizu, Kenichi Suda, Ryoichi Onozato, Takayuki Fukui, Simon Ito, Shunzo Hatooka, Taijiro Sueda, Toyoaki Hida, Yasushi Yatabe et al. · 2009 · Journal of Thoracic Oncology
  76. Molecular histology of lung cancer: From targets to treatments
    Steven L. Wood, Maria Pernemalm, Philip A.J. Crosbie, Anthony David Whetton · 2015 · Cancer Treatment Reviews
  77. Response to Treatment and Survival of Patients with Non-Small Cell Lung Cancer Undergoing SomaticEGFRMutation Testing
    Lecia Van Dam Sequist, Victoria A. Joshi, Pasi Antero Janne, Alona Muzikansky, Panos M. Fidias, Matthew M. Meyerson, Daniel A. Haber, Raju Kucherlapati, Bruce Evan Johnson, Thomas James Lynch · 2007 · The Oncologist
  78. Analysis of Racial/Ethnic Representation in Select Basic and Applied Cancer Research Studies
    Santiago Xavier Guerrero, Andrés López‐Cortés, Alberto Indacochea, Jennyfer M. Garcí­a-Cárdenas, Ana Karina Zambrano, Alejandro Cabrera‐Andrade, Patricia Guevara‐Ramírez, Diana Abigail González, Paola Leone, César Paz‐y‐Miño · 2018 · Scientific Reports
  79. Sex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adducts
    Steen K. Mollerup, Gisle Berge, Rita Bæra, Vidar Skaug, Alan J. Hewer, David H. Phillips, Lodve B. Stangeland, Aage Haugen · 2006 · International Journal of Cancer
  80. EGFR and erbB2 mutation status in Japanese lung cancer patients
    Hidefumi Sasaki, Shigeki Shimizu, Katsuhiko Endo, Minoru Takada, Masaaki Kawahara, Hisaichi Tanaka, Akihide Matsumura, Keiji Iuchi, Hiroshi Haneda, Eriko Suzuki et al. · 2005 · International Journal of Cancer
  81. Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers
    Costa, Daniel B., Kobayashi, Susumu, Tenen, Daniel G., Huberman, Mark S. · 2007 · Lung Cancer
  82. Personalized medicine in lung cancer: what we need to know
    Tony S.K. Mok · 2011 · Nature Reviews Clinical Oncology
  83. Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression
    Rafael Rosell, Laia Perez‐Roca, José Javier Sánchez, Manuel Cobo, Teresa Morán, Imane CHAIB-OUKADOUR, Mariano Provencio, Manuel Dómine, María Ángeles Sala, Ulpiano Jiménez et al. · 2009 · PLoS ONE
  84. Role of Epidermal Growth Factor Receptor Pathway–Targeted Therapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
    Ezra E.W. Cohen · 2006 · Journal of Clinical Oncology
  85. EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer
    Jason H. Smouse, Edmund S. Cibas, Pasi Antero Janne, Victoria A. Joshi, Kelly H. Zou, Neal Ian Lindeman · 2009 · Cancer Cytopathology
  86. Next generation sequencing in clinical medicine: Challenges and lessons for pathology and biomedical informatics
    Rama R. Gullapalli, Ketaki Desai, Lucas Santana‐Santos, Jeffrey A. Kant, Michael J. Becich · 2012 · Journal of Pathology Informatics
  87. Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non–Small Cell Lung Cancer
    Stephen S. F. Yip, John Kim, Thibaud P. Coroller, Chintan Parmar, Emmanuel Rios Velazquez, Elizabeth Huynh, Raymond H. Mak, Hugo J.W.L. Aerts · 2016 · Journal of Nuclear Medicine
  88. Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L
    Urata, Yoshiko, Katakami, Nobuyuki, Morita, Satoshi, Kaji, Reiko, Yoshioka, Hiroshige, Seto, Takashi, Satouchi, Miyako, Iwamoto, Yasuo, Kanehara, Masashi, Fujimoto, Daichi et al. · 2016 · Journal of Clinical Oncology
  89. Somatic Mutations in the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor (EGFR) Abrogate EGFR-Mediated Radioprotection in Non–Small Cell Lung Carcinoma
    Amit Kumar Das, Benjamin P. Chen, Michael D. Story, Mitsuo Sato, John Dorrance Minna, David J. Chen, Chaitanya S. Nirodi · 2007 · Cancer Research
  90. ALKMolecular Phenotype in Non–Small Cell Lung Cancer: CT Radiogenomic Characterization
    Shota Yamamoto, Ronald Lee Korn, Rahmi Öklü, Christopher Migdal, Michael B. Gotway, Glen J. Weiss, Anthony John Iafrate, Dong‐Wan Kim, Michael Kuo · 2014 · Radiology
  91. Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma
    John K. Wiencke, Shichun Zheng, Nanette Jelluma, Tarık Tihan, Scott R. VandenBerg, Tanja Tamgüney, Rachel Baumber, Ramon E. Parsons, Kathleen R. Lamborn, Mitchel Stuart Berger et al. · 2007 · Neuro-Oncology
  92. Leveraging big data to transform target selection and drug discovery
    Bin Chen, Atul Janardhan Butte · 2015 · Clinical Pharmacology & Therapeutics
  93. Crizotinib resistance: implications for therapeutic strategies
    Ibiayi Dagogo‐Jack, Alice Tsang Shaw · 2016 · Annals of Oncology
  94. First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study
    Seiji Niho, Kaoru Kubota, Kōichi Goto, Kiyotaka Yoh, Hironobu Ohmatsu, Ryutaro Kakinuma, Nagahiro Saijo, Yutaka Nishiwaki · 2005 · Journal of Clinical Oncology
  95. Anti‐angiogenic drugs: from bench to clinical trials
    Ana R. Quesada, Ramón Muñoz‐Chápuli, Miguel Ángel Medina · 2006 · Medicinal Research Reviews
  96. Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas
    Cortot, Alexis B., Jänne, Pasi A. · 2014 · European Respiratory Review
  97. Proapoptotic BH3-Only BCL-2 Family Protein BIM Connects Death Signaling from Epidermal Growth Factor Receptor Inhibition to the Mitochondrion
    Jing Deng, Takeshi Shimamura, Samanthi A. Perera, Nicole E. Carlson, Dongpo Doug Cai, Geoffrey Ira Shapiro, Kwok‐Kin Wong, Anthony G. Letai · 2007 · Cancer Research
  98. Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer
    Marta Salido, Lara Pijuán, Luz Maria Martinez-Aviles, Ana B. Galván, Israel Cañadas, Ana Rovira, Montserrat Zanui, Alejandro Martínez, Raquel Longarón, Francesc Gessé Solé et al. · 2010 · Journal of Thoracic Oncology
  99. Molecular Mechanisms Underlying the Synergistic Interaction of Erlotinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, with the Multitargeted Antifolate Pemetrexed in Non-Small-Cell Lung Cancer Cells
    Elisa Giovannetti, Clara Lemos, Christina Tekle, Kees Smid, Sara Nannizzi, José Antonio Rodríguez, Simona Ricciardi, Romano Danesi, Giuseppe Giaccone, Godefridus J. Peters · 2008 · Molecular Pharmacology
  100. Loss of PTEN expression by blocking nuclear translocation of EGR1 in gefitinib-resistant lung cancer cells harboring epidermal growth factor receptor-activating mutations
    Yamamoto, Chizuko, Basaki, Yuji, Kawahara, Akihiko, Nakashima, Kazutaka, Kage, Masayoshi, Izumi, Hiroto, Kohno, Kimitoshi, Uramoto, Hidetaka, Yasumoto, Kosei, Kuwano, Michihiko et al. · 2010 · Cancer Research